PTX has been having a bad run over the last year or two. It has been bashed and heavily shorted, the dreaded debt and SEC standards issues added to this.
Recently under the new leadership of veteran Sedor, the company has restructured its operations and staffing, added new product in pediatric pain medicine, added new patent in Japan and has a number of drugs in...
